Quantitative T1rho mapping links the cerebellum and lithium use in bipolar disorder.
Quantitative T1rho mapping links the cerebellum and lithium use in bipolar disorder.
复制标题
DOI:
10.1038/mp.2015.10
复制
发表时间:
2015-02-01
影响因子:
11
通讯作者:
Wemmie, J A
中科院分区:
文献类型:
--
作者:
Johnson, C P;Follmer, R L;Wemmie, J A
Bipolar I disorder is a common and debilitating disorder for which the causes remain unknown and treatments are often inadequate. Also unclear are the mechanisms by which lithium and other therapies reduce bipolar symptoms. Here, participants with bipolar I disorder in the euthymic state were imaged using a novel magnetic resonance brain imaging technique referred to as quantitative T1ρ mapping. The T1ρ relaxation time, which is sensitive to metabolic factors (for example, pH and glucose) as well as tissue microstructural properties (for example, cellular density), was calculated at each voxel over the whole brain. The data suggest several differences in the bipolar group including increased T1ρ relaxation times in the cerebellum relative to 25 participants without bipolar disorder (Johnson et al.). The data further suggest a potentially interesting effect of lithium. Of the 15 participants with bipolar disorder, six were taking lithium (Li+ group) and nine were not (Li− group). Average T1ρ maps were calculated for the Li+ and Li− groups in a common atlas space, and the average group whole-brain maps were compared voxel-by-voxel (Po0. 05, corrected). The figure shows (from top to bottom) coronal, axial, sagittal and three-dimensional views of the voxels that were significantly elevated in the Li− group compared with the Li+ group (red, gray matter; yellow, white matter). These images suggest T1ρ is elevated in the cerebellum in bipolar disorder and may be normalized with lithium use. On the basis of the known sensitivities of T1ρ, these abnormalities may be metabolic or structural in origin. Studying more participants with bipolar disorder as well as other illnesses, and further characterizing the T1ρ-mapping technique may lead to a more precise understanding of these T1ρ abnormalities, and may help guide the search for new therapies. For more information on this topic, please refer to the article by Johnson et al. on pages 201-206.